(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Bronchiectasis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Bronchiectasis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Bronchiectasis. DelveInsight's Report also assesses the Bronchiectasis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Marketed Details of Drugs by Application Type Marketed Details of Drugs (NDA) by Marketing Status Marketed Details of Drugs by Patent Expiration Timeline Global API Manufacturers Assessment API Manufacturers by United States Drug Master File (US DMF) Status API Manufacturers by US DMF Status (Drug Specific) API Manufacturers in Europe by Country API Manufacturers in India by State API Manufacturers in China by Province
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
